Clinical Trials Logo

Meningomyelocele clinical trials

View clinical trials related to Meningomyelocele.

Filter by:

NCT ID: NCT06405698 Not yet recruiting - Myelomeningocele Clinical Trials

Role of Perforator Flaps in Back Defects Reconstruction

Start date: May 2024
Phase: N/A
Study type: Interventional

evaluation of perforator flaps versus perforator plus flaps

NCT ID: NCT06301802 Recruiting - Urologic Diseases Clinical Trials

Outcomes of Proactive Management of Children With Myelomeningocele

Start date: March 4, 2024
Phase:
Study type: Observational

Spina bifida birth prevalence in Africa is 0.13%. Myelomeningocele (MMC) represents the most frequent and most severe cause of NB in children. Treatment of neuropathic bladder secondary to spina bifida is an ongoing challenge. Damage of the renal parenchyma in children with NB is preventable given adequate evaluation, follow-up and proactive management. Proactive management was defined as use of clean intermittent catheterization (CIC), and/or anticholinergics at presentation, or based on initial high-risk urodynamic findings by 1 year of age. The proactive approach to treat SB (CIC and pharmacotherapy) has contributed to decreasing chronic kidney disease (CKD). Myelomeningocele is considered a complex congenital disease. Hence, a multidisciplinary team is the best choice for management of spina bifida, involving neurosurgeons, orthopedic surgeons, urologists, physical medicine and rehabilitation specialists and pediatricians. Currently, children with spina bifida in Egypt must visit multiple different locations to access the complex care they need. Here, we review our experience with patients with spina bifida who will be followed with this team with an emphasis on patients' upper urinary tract protection and decreasing urinary incontinence.

NCT ID: NCT06042140 Recruiting - Myelomeningocele Clinical Trials

Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair

HUC-FICS
Start date: September 8, 2023
Phase: N/A
Study type: Interventional

The objective is to test the efficacy of a laparotomy-assisted fetoscopic surgical approach to cover spina bifida spinal cord developmental defects using cryopreserved human umbilical cords (NEOX Cord 1K®) as a meningeal and skin patch.

NCT ID: NCT05711355 Completed - Clinical trials for Meningomyelocele/Spina Bifida

the Effects of Platelet-Rich Plasma on Postoperative Complications After Meningomyelocele

Start date: January 15, 2022
Phase: N/A
Study type: Interventional

Introduction: Meningomyelocele is a common congenital neural tube defect. To reduce complications, early surgery and a multidisciplinary approach is needed. In this study, the investigators administered platelet-rich plasma (PRP) to newborns with meningomyelocele following corrective surgery to minimize cerebrospinal fluid (CSF) leakage and accelerate the healing of the immature pouch tissue. The investigators compared these with a control group that did not receive PRP. Patients and Methods: Of the 40 newborns who were operated on with the diagnosis of meningomyelocele, 20 patients received PRP after surgical repair, and 20 were followed up without PRP. In the PRP group, 10 of the 20 patients underwent primary defect repair, the other 10 underwent flap repair. In the group that did not receive PRP, primary closure was performed in 14 patients and flap closure in six.

NCT ID: NCT05188300 Completed - Meningomyelocele Clinical Trials

Propellers Flaps for Meningomylocele Defects

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

To evaluate reliability of free style propeller perforator flap for coverage MMC soft tissue defect follow a well-established step that overcome the usual problem of pedicled perforators propellers flaps.

NCT ID: NCT04789746 Enrolling by invitation - Cerebral Palsy Clinical Trials

Ready, Set, Go! A Physical Fitness Intervention for Children With Mobility Challenges

Start date: February 20, 2019
Phase: N/A
Study type: Interventional

Barriers to keeping and maintaining fitness as a young person with a disability exist across many domains of access to community locations such as fitness centers, so looking outside of these establishments may be necessary to advance fitness. This study is aimed at piloting a program that would address some of these barriers by hosting a modified after school running program with an underserved population in an accessible way. There is a second option to participate outside of school.

NCT ID: NCT04770805 Recruiting - Spina Bifida Clinical Trials

In Utero Fetoscopic Repair Program for Sacral Myelomeningoceles and Mye-LDM

PRIUM2
Start date: April 16, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the feasibility and the maternal, fetal and postnatal outcomes of sacral myelomeningocele (MMC) and Myelic Limited Dorsal Myeloschisis (MyeLDM) fetoscopic repair at Trousseau Hospital (Paris, France).

NCT ID: NCT04738539 Recruiting - Urologic Diseases Clinical Trials

Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies

Start date: March 2, 2021
Phase:
Study type: Observational

The investigators will assess the feasibility of replacing fluoroscopy/iodinated contrast with ultrasound/sulfur hexafluoride lipid-type A microspheres during routine urodynamic studies.

NCT ID: NCT04652908 Recruiting - Myelomeningocele Clinical Trials

Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial

CuRe
Start date: June 21, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Spina bifida, or myelomeningocele (MMC), is a disorder where the lower part of the spinal cord of the fetus is exposed, meaning there is no bone or skin covering it. This is dangerous because the spinal cord contains cells which control one's ability to move their legs and walk, and also to be able to urinate and have bowel movements normally. One of the current treatments for fetal MMC is to perform a surgery on the fetus before it is born which has many names including in utero surgery, prenatal surgery, or fetal surgery. This is a surgery that occurs inside the uterus (the womb) where the surgeon closes the opening in your fetus' back to cover the exposed spinal cord. Researchers have found that adding stem cells to the repair is effective in improving the ability of animals with MMC to walk, and that the stem cells are safe in animal studies. These stem cells are thought to protect the cells in the spinal cord that control movement and developmental outcomes. This study is being performed to look at the safety and effectiveness of stem cells on the fetus's exposed spinal cord during prenatal surgery.

NCT ID: NCT04484441 Active, not recruiting - Spina Bifida Clinical Trials

Maternal-fetal Immune Responses to Fetal Surgery

Start date: March 24, 2022
Phase:
Study type: Observational

Performing surgery in utero on fetuses with certain birth defects has led to significant improvements in outcomes after birth; however, many of these infants are born preterm which can decrease the effectiveness of these procedures. The investigators aim to understand the effects of surgery on the maternal and fetal immune system and whether immune activation may be causing some of these infants to be born prematurely.